HMGCR and type 2 diabetes mellitus: The presence of a defective allele in the 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) gene, which encodes the statin target, was consistently associated with an increased risk of T2DM, at least partially mediated by increased body weight [180].